Towards Healthcare
Cell and Gene Therapy Drug Delivery Devices Market Forecast 2025 to 2034

Cell and Gene Therapy Drug Delivery Devices Market Future Trends

The market is growing due to the demand for safe and efficient delivery of advanced cell and gene therapies. Technological innovations and increasing clinical adoption are accelerating the market’s expansion in North America.

Content

  • Insight Code: 6096
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: September 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

Cell & gene therapy devices market set to rise sharply from 2025 to 2034 with tech-driven innovation.

North America is currently leading the cell and gene therapy drug delivery devices market due to its benefits from a robust ecosystem of research institutions, CDMOs, and specialized treatment centers focused on cell and gene therapies.

The cell and gene therapy drug delivery devices market includes six segments by product/device type, by therapy type/use case, by delivery route, by technology/features, by end user, and by region.

Some key players include Baxter International, Becton, Dickinson & Company (BD), B. Braun Melsungen, Terumo Corporation, Medtronic, and ICU Medical.

Key trends include the growth due to the demand for safe and efficient delivery of advanced cell and gene therapies.

India Brand Equity Foundation, Food and Drug Administration, U.S. Environmental Protection Agency, European Medicines Agency, and National Medical Products Administration.
Any Questions